Twenty years of changes in the definition of early chronic obstructive pulmonary disease.

Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory airway disease that affects the quality of life of nearly one-tenth of the global population. Due to irreversible airflow obstruction and progressive lung function decline, COPD is characterized by high mortality and disability rates, which imposes a huge economic burden on society. In recent years, the importance of intervention in the early stage of COPD has been recognized and the concept of early COPD has been proposed. Identifying and intervening in individuals with early COPD, some of whom have few or no symptoms, might halt or reverse the progressive decline in lung function, improve the quality of life, and better their prognosis. However, understanding of early COPD is not yet well established, and there are no unified and feasible diagnostic criteria, which complicates clinical research. In this article, we review evolution of the definition of early COPD over the past 20 years, describe the changes in awareness of this concept, and propose future research directions.
Competing Interests: Dr. Curtis participated in the following COPD-relevant industry-sponsored activities: AstraZeneca PLC, consultant, AstraZeneca Respiratory Advisory Council, 09/16/2020–12/31/2021, $1362, paid to University of Michigan; CSL Behring, LLC 199240, consultant, Virtual Nebulized Immunoglobulin (NebIg) Advisory Board, 02/01/2021–2/23/2022, $2500, paid to University of Michigan.
(© 2023 Published by Elsevier B.V. on behalf of Chinese Medical Association.)